Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Mizuho Financial
MFG
$126B
| $532K | ﹤0.01% |
173,225
+90,627
| +110% | +$269K |
|
3027
Climb Global Solutions
CLMB
$497M
| $532K | ﹤0.01% |
+44,436
| New | +$541K |
|
3028
Atomera
ATOM
$197M
| $531K | ﹤0.01% |
60,592
+5,813
| +11% | +$45.9K |
|
3029
IBEX
IBEX
$475M
| $531K | ﹤0.01% |
25,006
+4,332
| +21% | +$92.6K |
|
3030
RBB Bancorp
RBB
$446M
| $530K | ﹤0.01% |
44,401
+5,088
| +13% | +$61.2K |
|
3031
BayCom
BCML
$330M
| $530K | ﹤0.01% |
31,749
-628
| -2% | -$10.4K |
|
|
HT
3032
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $528K | ﹤0.01% |
86,711
+550
| +0.6% | +$3.38K |
|
3033
Plumas Bancorp
PLBC
$426M
| $527K | ﹤0.01% |
+14,770
| New | +$522K |
|
3034
Safe Bulkers
SB
$810M
| $527K | ﹤0.01% |
161,524
-1,755
| -1% | -$6.16K |
|
|
THRX
3035
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $524K | ﹤0.01% |
56,203
+11,092
| +25% | +$109K |
|
3036
Ramaco Resources Class A
METC
$639M
| $524K | ﹤0.01% |
64,210
+968
| +2% | +$8.07K |
|
3037
ORIX
IX
$44.1B
| $521K | ﹤0.01% |
28,585
+15,615
| +120% | +$271K |
|
|
USX
3038
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $521K | ﹤0.01% |
84,833
+62,836
| +286% | +$381K |
|
3039
The Honest Company
HNST
$409M
| $520K | ﹤0.01% |
309,236
-146,773
| -32% | -$250K |
|
3040
Information Services Group
III
$197M
| $516K | ﹤0.01% |
96,352
-1,293
| -1% | -$6.7K |
|
|
CVLY
3041
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $516K | ﹤0.01% |
+26,301
| New | +$500K |
|
3042
Gossamer Bio
GOSS
$87.2M
| $515K | ﹤0.01% |
428,805
-33,892
| -7% | -$42.2K |
|
3043
Lineage Cell Therapeutics
LCTX
$277M
| $512K | ﹤0.01% |
363,215
+295,032
| +433% | +$408K |
|
|
TEAD
3044
Teads Holding Co
TEAD
$70.3M
| $512K | ﹤0.01% |
104,063
+4,712
| +5% | +$20.7K |
|
3045
HF Foods Group
HFFG
$80.2M
| $512K | ﹤0.01% |
109,095
+6,454
| +6% | +$25.3K |
|
|
TAST
3046
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $509K | ﹤0.01% |
101,001
+90,273
| +841% | +$409K |
|
3047
Southern First Bancshares
SFST
$579M
| $508K | ﹤0.01% |
20,510
+69
| +0.3% | +$1.8K |
|
3048
Silvercrest Asset Management
SAMG
$76.1M
| $507K | ﹤0.01% |
25,027
+106
| +0.4% | +$2.03K |
|
3049
Century Therapeutics
IPSC
$395M
| $506K | ﹤0.01% |
160,058
+8,271
| +5% | +$26.7K |
|
|
KG
3050
Kestrel Group
KG
$67.1M
| $505K | ﹤0.01% |
12,022
+10,374
| +629% | +$443K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.